Ci Medical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Retailing
  • ISIN: JP3346190006
JPY
1,493.00
1 (0.07%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
22,988.00
23,476.00
22,657.00
22,245.00
20,932.00
12,370.00
11,946.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
22,988.00
23,476.00
22,657.00
22,245.00
20,932.00
12,370.00
11,946.00
Raw Material Cost
14,755.00
15,126.00
14,981.00
14,360.00
13,748.00
9,183.00
8,914.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
22.00
13.00
37.00
23.00
19.00
13.00
6.00
Selling and Distribution Expenses
7,037.00
6,932.00
6,967.00
6,499.00
7,059.00
2,606.00
2,620.00
Other Expenses
-2.20
-1.30
-3.70
-2.30
-1.90
-0.80
-0.20
Total Expenditure (Excl Depreciation)
21,792.00
22,058.00
21,948.00
20,859.00
20,807.00
11,794.00
11,538.00
Operating Profit (PBDIT) excl Other Income
1196
1418
709
1386
125
576
408
Other Income
61.00
384.00
128.00
-24.00
210.00
-27.00
-9.00
Operating Profit (PBDIT)
1,549.00
2,106.00
1,193.00
2,047.00
887.00
1,098.00
949.00
Interest
22.00
13.00
37.00
23.00
19.00
13.00
6.00
Exceptional Items
-180.00
-48.00
1,362.00
-226.00
4,729.00
-6.00
0.00
Gross Profit (PBDT)
8,233.00
8,350.00
7,676.00
7,885.00
7,184.00
3,187.00
3,032.00
Depreciation
292.00
304.00
356.00
685.00
552.00
549.00
550.00
Profit Before Tax
1,057.00
1,740.00
2,162.00
1,109.00
5,048.00
528.00
393.00
Tax
326.00
502.00
707.00
167.00
278.00
189.00
143.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
741.00
1,100.00
1,367.00
930.00
4,759.00
330.00
248.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
741.00
1,100.00
1,367.00
930.00
4,759.00
330.00
248.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-11.00
138.00
88.00
13.00
11.00
8.00
2.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
730.00
1,238.00
1,455.00
943.00
4,770.00
338.00
250.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
28,677.00
27,890.00
26,817.00
26,095.00
25,061.00
20,423.00
20,062.00
Earnings per share (EPS)
14.82
22.0
27.34
18.58
95.2
6.6
4.94
Diluted Earnings per share
14.82
22.0
27.34
18.58
95.2
6.6
4.94
Operating Profit Margin (Excl OI)
5.2%
6.04%
3.13%
6.23%
0.6%
4.66%
3.42%
Gross Profit Margin
5.87%
8.71%
11.11%
8.06%
26.75%
8.71%
7.89%
PAT Margin
3.22%
4.69%
6.03%
4.18%
22.74%
2.67%
2.08%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Sep 2025 is 9.82% vs 82.80% in Sep 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Sep 2025 is -84.70% vs 815.55% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Sep 2025 is 119.79% vs -32.97% in Sep 2024

stock-summary

Interest

YoY Growth in quarter ended Sep 2025 is 15.79% vs 0.00% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024

Compare Quarterly Results Of Ci Medical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
22,988.00
1,64,320.00
-1,41,332.00
-86.01%
Other Operating Income
0.00
0.00
0.00
Total Operating income
22,988.00
1,64,320.00
-1,41,332.00
-86.01%
Raw Material Cost
14,755.00
1,51,416.00
-1,36,661.00
-90.26%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
22.00
22.00
0.00
Selling and Distribution Expenses
7,037.00
11,426.00
-4,389.00
-38.41%
Other Expenses
-2.20
-2.20
0.00
Total Expenditure (Excl Depreciation)
21,792.00
1,62,842.00
-1,41,050.00
-86.62%
Operating Profit (PBDIT) excl Other Income
1,196.00
1,478.00
-282.00
-19.08%
Other Income
61.00
199.00
-138.00
-69.35%
Operating Profit (PBDIT)
1,549.00
2,719.00
-1,170.00
-43.03%
Interest
22.00
22.00
0.00
Exceptional Items
-180.00
-12.00
-168.00
-1,400.00%
Gross Profit (PBDT)
8,233.00
12,904.00
-4,671.00
-36.20%
Depreciation
292.00
1,042.00
-750.00
-71.98%
Profit Before Tax
1,057.00
1,644.00
-587.00
-35.71%
Tax
326.00
691.00
-365.00
-52.82%
Provisions and contingencies
0
0
0.00
Profit After Tax
741.00
921.00
-180.00
-19.54%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
741.00
921.00
-180.00
-19.54%
Share in Profit of Associates
0
0
0.00
Minority Interest
-11.00
31.00
-42.00
-135.48%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
730.00
952.00
-222.00
-23.32%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
28,677.00
1,09,985.00
-81,308.00
-73.93%
Earnings per share (EPS)
14.82
19.04
-4.22
-22.16%
Diluted Earnings per share
14.82
19.04
-4.22
-22.16%
Operating Profit Margin (Excl OI)
5.20%
0.90%
0.00
4.30%
Gross Profit Margin
5.87%
1.63%
0.00
4.24%
PAT Margin
3.22%
0.56%
0.00
2.66%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 2,298.80 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -2.08% vs 3.61% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 9.82% vs 82.80% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 73.00 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -41.03% vs -14.91% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -84.70% vs 815.55% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 148.80 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -13.59% vs 61.69% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 119.79% vs -32.97% in Sep 2024

Quarterly - Interest
Interest 2.20 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 69.23% vs -64.86% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 15.79% vs 0.00% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 5.20%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024